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exhibited progressive thinning with dilatation and
aneurysm,5,9,10 or were incorporated into the host tis-
sue.3-6 Retraction and fibrosis were observed when
fresh pericardium was used as a patch or artificial chor-
dae in heart valve reconstruction.7,8,11,12 The closure of
large ventricular defects or patch reconstruction of the
right ventricular outflow tract with distal pulmonary
hypertension was reported to result in aneurysmal
changes.5,9,10,13-16 In contrast, growth potential was doc-
umented in broad-based pedicled pericardial flaps
implanted as atrial wall replacements or right-sided
conduits in dogs and human beings in whom adequate
blood supply was able to support tissue viability.3-5 The
clinical use of fresh autologous pericardium in cardio-
vascular surgery is limited because of these uncertain
outcomes. In an attempt to clarify this issue, fresh autol-
ogous pericardium containing living cells and the same
tissue treated with 50% ethanol (ethanol-killed), which
V ital (fresh) autologous pericardium is a low costbiomaterial that has advantages for cardiovascular
implantation. It is free of donor-derived pathogens, will
not provoke an immune response, shows growth poten-
tial, and is easy to access.1-6 However, the use of fresh
autologous pericardium as an implant has shown mixed
results. The implants became fibrotic and retracted,7,8
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killed vital cells, were implanted in the descending tho-
racic aorta of sheep as a patch in the aortic wall, a con-
duit, and an intraluminal flap. Although the patch and
the conduit implants were part of the aortic wall with
the mesothelial surface contacting the blood, both sur-
faces of the intraluminal flap were exposed to blood,
thus mimicking a heart valve leaflet. In this study,
sequential analyses of the gross, microscopic, and
immunohistochemical data were used to evaluate the
behavior of this surgical biomaterial. 
Methods
Fourteen Targhee sheep between 4 and 10 months old, 28
to 52 kg (36 ± 7.6 kg), were used. All animals were treated
perioperatively with broad-spectrum antibiotics. General
anesthesia was induced with ketamine (1.0 mg/kg) and
propofol (4.0 mg/kg) intravenously and maintained with oxy-
gen (4 L/min), isoflurane gas (1.5% to 2.5%), and half-bolus
doses of propofol during the operation as needed. The chest
wall was opened through the left 4th intercostal space. The
descending thoracic aorta was dissected and a 10-cm segment
mobilized. A 6 · 10-cm rectangular piece of pericardium was
harvested, with markers being placed to maintain the original
craniocaudal pericardial orientation. For animals receiving
ethanol-killed implants, the pericardial tissues were treated
with 50% ethanol for 5 minutes and rinsed in phosphate-
buffered saline solution (PBS).
A patch of approximately 1.5 · 2 cm was resected from the
harvested pericardium, followed by the construction of a 1.5-
cm diameter · 2-cm long conduit. The conduit was construct-
ed by folding the pericardium with the mesothelial surface
facing the lumen around a glass cylinder and suturing the free
edges with a 5-0 polypropylene continuous running suture.
Finally, a 1.5 · 2-cm segment was resected from the peri-
cardium to be used as an intraluminal flap, bisecting the aorta.
All these implants were oriented so that the craniocaudal
direction of the pericardium was parallel to the aortic flow. 
The descending thoracic aorta was isolated with cross-
clamps placed distal to the arch vessel (in sheep there is only
1 main vessel arising from the arch) and proximal to the take-
off of the first major intercostal or spinal artery. The animals
were heparinized to maintain an accelerated clotting time
above 300 seconds, after which an apicofemoral shunt was
created to bypass the isolated segment of the descending tho-
racic aorta that received the implants. The patch was used to
close a defect created in the aortic wall distal to the cross-
clamp with a continuous running 5-0 polypropylene suture.
The patch was oriented with the mesothelial surface facing
the aortic lumen. The aorta was transected distal to the
implanted patch and incised longitudinally along its anterior
margin for a distance of 2 cm. One edge of the intraluminal
flap was sutured to the aortic wall directly opposite the lon-
gitudinal incision and the opposite edge was sandwiched
under tension between the walls of the aortic incision as the
aorta was being closed with a continuous running 5-0
polypropylene suture. Finally, the pericardial conduit was
positioned between the proximal and distal ends of the tran-
sected aorta with continuous running 5-0 polypropylene
sutures (Fig 1). On completion of the operation, protamine
was administered at 1.5 times the total heparin dosage with
further adjustments determined by the accelerated clotting
time. The chest was closed in layers and a chest tube was
inserted. After extubation, the chest tube was removed and
the animal transferred to its pen. 
The control animals (n = 1) for both the fresh and ethanol-
killed groups were killed on day 1. Subsequent animals were
killed 5, 10, 15, and 30 days after the operation. The group
with fresh tissue consisted of 2 animals per time point, and
the group with ethanol-killed tissue consisted of 1 animal per
time point. To prevent postmortem intraluminal clotting, the
animals were fully heparinized (300U/kg) before being put to
death. The sheep were killed with 1% propofol and 20 mL of
potassium chloride (US Pharmacopeia 20 mEq/mL) by injec-
tion. The descending aorta was harvested en bloc to include
all 3 pericardial implants and a 1-cm margin of normal aortic
Fig 1. Configuration of autologous pericardial implants in the descending aorta of sheep. The pericardium was
implanted as a patch (p), conduit (c), and flap (f).
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tissue. The aorta was split longitudinally for gross observa-
tion of the degree of fibrosis, dilatation or thinning, thicken-
ing, and retraction. 
All animals were cared for in accordance with the
“Principles of Laboratory Animal Care” formulated by the
National Society of Medical Research and the “Guide for the
Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press,
revised 1996. The use of the animals for this research was
also reviewed and approved by the Institutional Animal Care
and Use Committee (IACUC) of the University of Montana. 
Histology. The specimens were fixed in Histo-Choice fix-
ative (Amresco Inc, Solon, Ohio), embedded, and sectioned
for histologic study. The patch and conduit were sectioned
parallel to the direction of blood flow and included the junc-
tion between the implants and the aortic wall. Cross sections
of the flap and aortic wall were made perpendicular to the
blood flow to observe the aortic wall and edges of the flap.
Sections were stained with hematoxylin and eosin, which
stains nuclei blue and collagen pink, and Masson’s trichrome,
which stains collagen blue and muscle red. 
Immunohistochemistry. Sections were cleared of paraffin
and treated with 1% hydrogen peroxide in methyl alcohol for
30 minutes to remove endogenous peroxidases. The sections
were blocked with 0.05% Tween-20 in phosphate buffered
saline solution (PBS-T) for 30 minutes to prevent nonspecif-
ic antibody binding. The sections were incubated with either
anti–smooth muscle cell a -actin (clone 1A4) or anti-human
von Willebrand–related antibodies for 30 minutes. Sections
were then washed with PBS-T. The sections were incubated
for 30 minutes with protein A–horseradish peroxidase.
Sections were washed with PBS-T and visualized with the
use of the horseradish peroxidase substrate DAB (Sigma Fast
DAB, Sigma Chemical Co, St Louis, Mo). Horseradish per-
oxidase is an enzyme and, in the presence of hydrogen per-
oxide, converts DAB into an insoluble dark brown precipitate
on the specimens. The development was stopped with water
and the slides counterstained with hematoxylin and eosin.
Controls included replacing either the antibody or protein A-
horseradish peroxidase with PBS-T followed by DAB devel-
opment. Sections were probed for von Willebrand–related
antigen, a known endothelial cell marker, and smooth muscle
cell a -actin, which is expressed in smooth muscle cells and
myofibroblasts. The antibodies, protein A–horseradish perox-
idase, Tween-20, and the DAB substrate were obtained from
A B
Fig 2. Gross histologic features of 30-day patch, conduit, and flap. A, The luminal aspect of the fresh patch (p)
and conduit (c) remained smooth, whereas the flap (f) was retracted and fibrotic. B, In contrast, the ethanol-killed
patch (p), conduit (c), and flap (f) were clean and smooth, showing no signs of fibrosis or retraction. 
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Sigma Chemical Co, St Louis, Missouri, and used according
to the manufacturer’s recommendations.
Results
Gross observations
Fresh pericardium. On day 5, fibrin accumulation
was found on the luminal aspects of the patch and con-
duit as well as both surfaces of the flap. On day 10, 1
flap showed thinning with sparse fibrin deposition and
the second showed thickening with heavy fibrin depo-
sition on both surfaces. The patch and conduit appeared
thickened on day 15, but the luminal surfaces were
smooth. The flap continued to thicken and appeared
contracted. On day 30, the luminal aspects of the patch
and conduit were smooth. There was extensive fibrosis
with thickening and retraction on the flap (Fig 2, A).
Ethanol-killed pericardium. On day 5, minimal fibrin
accumulation was found on the luminal aspects of the
patch, conduit, and flap, which remained constant
through day 10. By day 15, the patch and conduit
appeared thickened but were free of clot. The flap was
clean and free of fibrosis. The luminal aspects of the
30-day patch and conduit were smooth without fibrin
accumulation. The ethanol-killed flap was smooth, not
thickened, and free of clot (Fig 2, B).
Histologic findings 
Fresh 
DAY 1. Thin fibrin deposits containing polymor-
phonuclear leukocytes (PMNs) were seen on the lumi-
nal surface of the patch and conduit, as well as both
surfaces of the flap. 
DAY 5. Fibrin deposition and PMNs were present in
all fresh implants with the contiguous aorta similarly
affected. At all 3 sites, PMNs and spindle-shaped cells
that stained weakly for a -actin were observed near the
interface between the implant and the fibrin clot.
DAY 10. The luminal surfaces of the patch and conduit
showed increased fibrin deposition with cellular debris.
Cells that were weakly positive for a -actin were
observed near the luminal aspect of the patch and con-
A B
C D
Fig 3. Multiple layers of cells expressing a -actin were seen in the fibrin layers of the 15-day fresh patch (A) and
flap (B) and the ethanol-killed patch (C) and flap (D) at the junction with the host aorta. The arrow indicates the
junction of the implant and the aortic wall. Immunohistologic detection of a -smooth muscle actin counterstained
with hematoxylin and eosin (magnification · 100).
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duit oriented perpendicular to the implant surface.
Several layers of cells strongly expressing a -actin were
present in the fibrin layers on the surface of the
implants. A layer of cells expressing von Willebrand–
related antigen was observed on the luminal surface of
the fibrin. In the flap, different layers of fibrin deposi-
tion with various degrees of cellularity were observed
on both sides. More cellular activity was apparent at
the interface between the implant surface and the fibrin
clot than in the interior of the pericardial implant. Cells
expressing von Willebrand–related antigen and a -actin
were present at the junction of the fresh flap and aortic
wall, but no cells expressing von Willebrand–related anti-
gen were present on the surface or within the implant.
DAY 15. Multiple layers of cells strongly expressing
a -actin were seen at the junctions of the host upstream
aorta and the 15-day patch and conduit (Fig 3, A).
Between these cells and the original implant was a
layer of organized fibrin with a high degree of cellular-
ity. A discontinuous layer of cells expressing von
Willebrand–related antigen was present on the luminal
surface of the implants. Trichrome staining showed that
the collagen bundles within the pericardium appeared
to be dispersed by cells and new matrix. In the flap,
numerous cells expressing moderate levels of a -actin
were present at the fibrin-implant interface. Similar to
the patch and conduit, multiple layers of a -actin–posi-
tive cells were present at the junction between the aor-
tic wall and the fibrin layers of the flap (Fig 3, B). No
cells expressing von Willebrand–related antigen were
seen on the flap. Trichrome staining indicated the col-
lagen in the original pericardial tissue was dispersed by
the deposition of new matrix.
DAY 30. The patch and conduit implants were difficult
to distinguish from the surrounding aorta. The a -
actin–positive cells, also seen in the day 15 implants,
extended across the entire implant (Fig 4, A) and were
covered by a layer of endothelium-like cells expressing
von Willebrand–related antigen (Fig 5, A). Similar to day
15, trichrome staining revealed that newly deposited col-
lagen separated collagen bundles of the original implants
(Fig 6). While the patch and conduit were incorporated
A B
C D
Fig 4. At 30 days, a -actin–expressing cells extended across the entire fresh conduit (A). The fresh flap contained
randomly oriented cells that stained for a -actin with various intensities (B). The ethanol-killed conduit (C) and
flap (D) were being repopulated by cells expressing a -actin, presumably moving into the tissue from the host
aorta. Immunohistologic detection of a -actin, counterstained with hematoxylin and eosin (magnification · 100).
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into a functional structure, the flap was retracted and
fibrotic. The fibrotic tissue of the flap was vascularized
and contained randomly oriented cells that stained for a -
actin with various intensities (Fig 4, B). The movement
of multiple layers of a -actin–positive cells from the aor-
tic wall onto the implant appeared to be interrupted by
the deposition of new fibrin. No endothelium-like cells
were present on any portion of the flap (Fig 5, B). The
collagen matrix of the original flap implant was difficult
to identify by trichrome staining.
Ethanol-killed pericardium 
DAYS 1 AND 5. PMNs and clot were present on the sur-
faces of the ethanol-killed patch, conduit, and flap. By
day 5, the implants appeared the same as on day 1,
except that there was a noticeable reduction of the
amount of clot. No vital cells were observed in the
implants before day 5, indicating that 50% ethanol was
effective in killing all the cells in the autologous
implants (Fig 7). 
DAY 10. The patch and conduit had a thin fibrin layer
containing PMNs with no new fibrin deposition. There
were a -actin-expressing cells in the thin fibrin layer of
the luminal side of the implant close to the aortic wall.
Cells expressing von Willebrand–related antigen were
present on the luminal surface of the implants but had
not formed a continuous monolayer.
No new fibrin deposition was seen on the ethanol-
killed flap. Cells positive for a -actin were present at the
A
B
C D
Fig 5. The 30-day fresh conduit (A) was covered by a layer of cells expressing von Willebrand–related antigen,
characteristic of an endothelium. This surface layer of cells was absent on the surface of the fresh flap (B). The
layer of cells expressing von Willebrand–related antigen was also present on the ethanol-killed conduit (C) and
flap (D). Immunohistologic detection of von Willebrand–related antigen counterstained with hematoxylin and
eosin (magnification · 100).
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junction of the aortic wall and implant. An occasional
cell staining positive for von Willebrand–related antigen
was seen on both luminal sides of the implant.
DAY 15. The patch and conduit contained multiple
layers of spindled-shaped a -actin–positive cells with-
in the remodeled fibrin with few cells seen within the
original implant (Fig 3, C). A discontinuous layer of
cells expressing von Willebrand–related antigen was
also present on the luminal surface of the implants.
Trichrome staining showed the collagen bundles of
the original implant to be separated by new matrix. 
A thin fibrin layer was present on the flap with no
new fibrin deposition. The fibrin layer had been remod-
eled and contained cells, but the implant itself had very
few cells. Cells strongly expressing a -actin bridged
from the aortic wall into the fibrin layer of the implant
(Fig 3, D). A layer of cells expressing von Willebrand–
related antigen was beginning to cover the implant.
Trichrome staining revealed that new collagen was pro-
duced at the junction of the implant and aorta and with-
in the fibrin layer. 
DAY 30. The luminal surface of the patch and conduit
had multiple layers of spindle-shaped a -actin–positive
cells (Fig 4, C) with a continuous surface layer of cells
expressing von Willebrand–related antigen (Fig 5, C).
Cells were present within the implant, and trichrome
staining showed remodeled fibrin with new collagen
deposition. The ethanol-killed flap was repopulated by
a multilayer of spindle-shaped a -actin–expressing cells
that presumably came from the aortic wall (Fig 4, D).
In contrast to the fresh flap implant, there was a con-
tinuous layer of cells expressing von Willebrand–relat-
ed antigen on both surfaces of the ethanol-killed flap
implant (Fig 5, D). Trichrome staining showed the sur-
face fibrin was replaced by collagen. 
Discussion
The use of fresh autologous pericardium as a cardio-
vascular implant has been reported with mixed results.
The transplants have been shown to become fibrotic
and retracted,7,8 exhibit progressive thinning with
dilatation and aneurysm,5,9,10 or were incorporated into
the surrounding host tissue with growth potential.3-6 A
common feature was tissue thinning with reduction in
connective tissue cells or degenerative nucleic changes.
The native collagenous tissue has been shown to under-
go eventual disorganization and fragmentation. 
The current study was designed in 2 parts. The fresh
group provided a picture of the variability of host
responses to identical, nonantigenic and viable tissue
implanted in the same location but with different con-
figurations. The ethanol-killed group was studied to
alleviate the activation of cell types intrinsic to the
fresh tissue, which may be responsible for the fibrotic
reactions seen in the fresh flap. This experiment was
performed to determine whether autologous pericardi-
um transplants, devoid of vital cells, would resist fibro-
sis in the sheep, a model used in many preclinical stud-
ies of cardiovascular implants.
Histologic and immunohistologic examination of the
recovered fresh implants indicated that the initial
events of the host and the cells in the implants were
similar. However, the outcomes of the implants were
clearly different. In the fresh patch and conduit, a dis-
continuous layer of cells expressing von Willebrand–
related antigen, was present on the surface of the
implants covering several layers of a -actin–positive
cells. Once these multiple layers of cells were estab-
lished on the implant, there was no new fibrin deposi-
tion. In contrast, the fresh flap had a continuous depo-
sition of new fibrin, which seemed to block movement
Fig 6. Trichrome staining of the 30-day fresh patch indicated
that the collagen of the original implant was separated by the
deposition of new matrix (magnification · 100).
Fig 7. No vital cells were seen internal to the original peri-
cardium after ethanol treatment. Day 5 ethanol-killed flap
stained with hematoxylin and eosin (magnification · 100).
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of cells from the aortic wall into the implant. The cells
present within the implant expressed a -actin and
remained randomly oriented. It is likely that the activa-
tion of these cells was responsible for the contraction
and distortion of the original flap implant. No cells
expressing von Willebrand–related antigen were pre-
sent at any time on the surface of the flap. 
Comparison of the fresh and ethanol-killed pericar-
dial implants showed significantly different results,
particularly with respect to the flap. The ethanol-killed
tissue allowed for ordered recolonization of the
implant, formation of a surface layer of cells express-
ing von Willebrand–related antigen, characteristic of an
endothelium, and completely alleviated the fibrosis
seen in the fresh flap. Whether these differences are due
to the absence of living cells or to the extraction of fac-
tors from the pericardium is not known.
In our study, 50% ethanol treatment for 5 minutes
effectively killed all intrinsic cells, as indicated by the
absence of vital cells in recovered implants at early
time points. Ethanol treatment for 5 minutes was ade-
quate to penetrate the pericardium without causing the
tissue shrinkage seen with higher concentrations of
ethanol. Recent studies indicated that 80% ethanol may
change the structure of the tissue.17,18 We have not
found evidence that 50% ethanol significantly alters tis-
sue structure.
These findings open a new field of possible clinical
applications for the use of freshly obtained autologous
pericardium treated with ethanol, particularly as an
alternative material for valve reconstruction. Additional
experimentation is needed to better understand the
development of fibrosis observed with fresh autologous
pericardial implants. Larger sample numbers, more fre-
quent time points, and growth factor studies may allow
for identification of the initial stages of fibrosis. In
addition, long-term and calcium content studies need to
be performed to ensure the stability of ethanol-killed
implants. This laboratory is currently devising methods
to isolate fresh and ethanol-killed pericardial flap
implants from the aortic wall to prevent fibrotic contri-
butions from host cells. 
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